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Abstract. 
 
ROCK (Rho-kinase), an effector molecule 
of RhoA, phosphorylates the myosin binding subunit 
(MBS) of myosin phosphatase and inhibits the phos-
phatase activity. This inhibition increases phosphoryla-
tion of myosin light chain (MLC) of myosin II, which
is suggested to induce RhoA-mediated assembly of 
stress ﬁbers and focal adhesions. ROCK is also known 
to directly phosphorylate MLC in vitro; however, the 
physiological signiﬁcance of this MLC kinase activity is 
unknown. It is also not clear whether MLC phosphory-
lation alone is sufﬁcient for the assembly of stress ﬁbers 
and focal adhesions.
We have developed two reagents with opposing ef-
fects on myosin phosphatase. One is an antibody 
against MBS that is able to inhibit myosin phosphatase 
activity. The other is a truncation mutant of MBS that 
constitutively activates myosin phosphatase. Through 
microinjection of these two reagents followed by immu-
noﬂuorescence with a speciﬁc antibody against phos-
phorylated MLC, we have found that MLC phosphory-
lation is both necessary and sufﬁcient for the assembly 
of stress ﬁbers and focal adhesions in 3T3 ﬁbroblasts. 
The assembly of stress ﬁbers in the center of cells re-
quires ROCK activity in addition to the inhibition of 
myosin phosphatase, suggesting that ROCK not only 
inhibits myosin phosphatase but also phosphorylates 
MLC directly in the center of cells. At the cell periph-
ery, on the other hand, MLCK but not ROCK appears 
to be the kinase responsible for phosphorylating MLC. 
These results suggest that ROCK and MLCK play dis-
tinct roles in spatial regulation of MLC phosphoryla-
tion.
Key words: myosin phosphatase • myosin phosphory-
lation • stress ﬁbers • focal adhesions • RhoA
 
Introduction
 
Phosphorylation of regulatory light chain (MLC)
 
1
 
 of
myosin II plays a critical role in controlling actomyosin
contractility in both smooth muscle and nonmuscle cells
(Kamm and Stull, 1985; Moussavi et al., 1993; Somlyo and
Somlyo, 1994). MLC phosphorylation is regulated by the
balance of two enzymatic activities, i.e., myosin light chain
kinase(s) and myosin phosphatase. Myosin light chain ki-
 
nase (MLCK) is regulated by Ca
 
2
 
1
 
/calmodulin and is be-
lieved to be a major kinase in both smooth muscle and
nonmuscle cells. Heterotrimeric myosin phosphatase is
thought to be a major phosphatase in smooth muscle and
perhaps in nonmuscle cells (Hartshorne et al., 1998).
The holoenzyme of myosin phosphatase consists of
three subunits: a large subunit of 
 
z
 
130 kD with myosin
binding ability (called MBS here), a catalytic subunit of 38
kD (PP1c
 
d
 
), and a small subunit of 20 kD of unknown
function (Alessi et al., 1992; Shimizu et al., 1994; Shirazi et
al., 1994). MBS is a critical subunit as it can bind both my-
osin and the catalytic subunit, thus targeting the substrate,
myosin, with the phosphatase. Without MBS, the catalytic
subunit, PP1c
 
d
 
, shows rather weak phosphatase activity
toward phosphorylated myosin (Alessi et al., 1992; Hirano
et al., 1997; Johnson et al., 1997). The activity of MBS is
regulated by phosphorylation with various kinases includ-
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ing protein kinase A, ROCK (Rho-kinase) and unidenti-
fied kinases (Ichikawa et al., 1996b; Ito et al., 1997; Tot-
sukawa et al., 1999). For example, ROCK is shown to
phosphorylate MBS in the COOH-terminal region includ-
ing Thr 697 and Ser 854 (Kimura et al., 1996; Feng et al.,
1999a; Kawano et al., 1999), resulting in the inhibition of
phosphatase activity. This inhibition is suggested to be re-
sponsible for the RhoA-mediated Ca
 
2
 
1
 
-sensitization pro-
cess in smooth muscle (Somlyo and Somlyo, 1994; Hart-
shorne et al., 1998).
The ROCK-mediated inhibition of myosin phosphatase
is also suggested to cause RhoA-mediated assembly of
stress fibers and focal adhesions in nonmuscle cells (Chr-
zanowska-Wodnicka and Burridge, 1996; Kimura et
al.,  1996; Kawano et al., 1999). The inhibition of myosin
phosphatase appears to account for an increase in MLC
phosphorylation seen during serum stimulation of serum-
starved 3T3 cells, and the resultant contractility of actomy-
osin is proposed to induce stress fibers and focal adhesions
(Chrzanowska-Wodnicka and Burridge, 1996). Indeed,
BDM, an inhibitor of actomyosin contractility, was shown
to inhibit assembly of stress fibers and focal adhesions dur-
ing serum stimulation of 3T3 cells (Chrzanowska-Wod-
nicka and Burridge, 1996). Furthermore, a constitutively
active form of ROCK induced stress fibers and focal adhe-
sions (Leung et al., 1996; Amano et al., 1997; Ishizaki et
al., 1997), though the morphology of stress fibers is stellar
and somewhat different from that of stress fibers induced
by constitutively active Rho or lysophosphatidic acid. It
remains to be elucidated, however, whether MLC phos-
phorylation alone is responsible for the induction of stress
fibers and focal adhesions, because ROCK is known to
phosphorylate other substrates including moesin, adducin
and intermediate filament proteins (Kosako et al., 1997;
Fukata et al., 1998; Kimura et al., 1998). In addition to the
inhibition of myosin phosphatase, ROCK has also been re-
ported to directly phosphorylate MLC in vitro (Amano et
al., 1996). The physiological significance of this MLC ki-
nase activity remains to be established. If ROCK indeed
functions as an MLC kinase, it is then important to deter-
mine how the two MLC kinases, ROCK and MLCK regu-
late MLC phosphorylation in the same cell.
To investigate the physiological functions of myosin
phosphorylation in RhoA-mediated assembly of stress fi-
bers and focal adhesions, we have generated two reagents
with opposing effects on myosin phosphatase activities.
One is an antibody against MBS that is able to inhibit the
phosphatase activity of myosin phosphatase. The other is a
constitutively active mutant of MBS. Because the mutant
lacks the COOH-terminal region that contains the regula-
tory phosphorylation sites, it constitutively activates myo-
sin phosphatase. Microinjection of these two reagents fol-
lowed by immunofluorescence with an antibody specific to
phosphorylated MLC has allowed us to evaluate MLC
phosphorylation with single cells and to examine its roles
in microfilament assembly. We have found that MLC
phosphorylation is essential and sufficient for the forma-
tion of stress fibers and focal adhesions in 3T3 fibroblasts.
Our results with the combined use of the inhibitory anti-
body and an inhibitor of ROCK indicate that ROCK is
likely to phosphorylate MLC directly. This MLC kinase
activity and the inhibition of myosin phosphatase are both
 
essential for the assembly of stress fibers in the center of
cells. MLCK, on the other hand, is involved in microfila-
ment assembly in the cell periphery, indicating that ROCK
and MLCK have distinct roles in spatial regulation of
MLC phosphorylation.
 
Materials and Methods
 
Reagents, Proteins, and Antibodies
 
The polyclonal antibody against MBS (termed M130Ab) was raised in
rabbits against the bacterially expressed truncated protein of chicken
MBS containing residues 1–296 (Ichikawa et al., 1996a), and affinity puri-
fied using the same truncated protein. A monoclonal antibody against Ser
19-phosphorylated MLC was described previously (Sakurada et al., 1998).
A monoclonal antibody against vinculin was purchased from Sigma-
Aldrich. A monoclonal antibody against paxillin and a monoclonal anti-
body against FAK were purchased from Transduction Laboratories. A
polyclonal goat antibody against MLCK (a kind gift by Dr. de Lanerolle,
University of Illinois, Chicago, IL) was prepared and affinity purified as
described previously (de Lanerolle et al., 1987). Y-27632, a specific inhibi-
tor of ROCK, was kindly provided by Yoshitomi Pharmaceutical Indus-
tries, Ltd. (Osaka, Japan) and ML-9 was purchased from Calbiochem-
Novabiochem. Y-27632 and ML-9 were stored as 3 mM stock solution in
DMSO in 
 
2
 
80
 
8
 
C before use.
Trimeric myosin phosphatase was purified from chicken gizzard ac-
cording to the method of Alessi et al. (1992). Regulatory light chain of my-
osin II (MLC) was purified from bovine lung myosin II as described (Sell-
ers, 1991). Bacterial expression of truncated MBS proteins, residues 1–296
(called MBS
 
296
 
) and residues 278–415 (MBS
 
278-415
 
), was performed essen-
tially as described except that guanidine hydrochloride was omitted
(Hirano et al., 1997; Totsukawa et al., 1999). As the MBS
 
296 
 
protein
tended to aggregate during storage, microinjection experiments were per-
formed within 2–3 d after purification.
 
Cell Culture, Microinjection, and Immunofluorescence
 
Balb/c 3T3 fibroblasts were maintained in DME containing 10% calf se-
rum in an atmosphere of 5% CO
 
2
 
 and 95% air at 37
 
8
 
C. Epithelial type
normal rat kidney cells (NRK, ATCC CRL 1571) and REF-2A cells (SV-
40–transformed REF52 cells) were maintained in DME containing 10%
newborn calf serum. Serum-starved 3T3 cells were prepared by culturing
subconfluent Balb/c 3T3 cells for 3–5 d in DME without serum. To pre-
pare serum-starved 3T3 cells that were well separated from each other,
starved 3T3 cells were replated as follows: cells were detached by
trypsinization and trypsin was neutralized with 0.5 mg/ml soybean trypsin
inhibitor (Sigma-Aldrich) and 1% BSA. After washing with DME, cells
were replated on poly-
 
L
 
-lysine-coated coverslips, and allowed to attach to
coverslips for 2 h before microinjection.
Microinjection was performed as described (Yamakita et al., 1990).
The antibody (M130Ab, 5 mg/ml) and the truncated proteins (MBS
 
296
 
,
1 mg/ml; MBS
 
278-415
 
, 2 mg/ml) were dialyzed against injection buffer (10
mM potassium phosphate and 70 mM KCl, pH 7.2). FITC-dextran (Mo-
lecular Probes) was comicroinjected to identify injected cells. In some ex-
periments, antibody-injected cells were detected by Alexa 350–conjugated
anti-rabbit secondary antibody (Molecular Probes). After microinjection
of the antibody, serum-starved cells were incubated for 30 min to 2 h be-
fore fixation unless otherwise mentioned. In the microinjection experi-
ments with truncated MBS mutants, microinjected cells were incubated
for 30 min followed by serum stimulation for 10 min before fixation. In
some experiments, 10 
 
m
 
M Y-27632 or 10 
 
m
 
M ML-9 was added 30 min be-
fore microinjection. Microinjection was also performed with 3T3 cells
growing exponentially in the presence of serum. Each microinjection ex-
periment was performed at least three times.
Immunofluorescence was performed as described previously (Mat-
sumura et al., 1998). Rhodamine-conjugated phalloidin was used for F-actin
staining. Phase and fluorescence images were taken with an AT200 cooled
CCD camera (Photometric) and processed with a MicroTome image pro-
cessing software (VayTek; Fairfield).
 
Myosin Phosphatase Assay
 
Trimeric myosin phosphatase (38 nM) was first incubated with various
concentrations of M130Ab for 30 min on ice and then phosphatase activi- 
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ties were assayed at room temperature for 5 min with 
 
32
 
P-labeled MLC (5
 
m
 
M) in 30 mM Tris-HCl (pH 7.5), 0.1 M KCl, 2 mM MgCl
 
2
 
, and 0.1 mg/ml
BSA. The reaction was terminated by the addition of trichloroacetic acid
and BSA to final concentrations of 10% and 3 mg/ml, respectively. After
centrifugation, the radioactivities of the supernatants were determined by
Cerenkov counting. 
 
32
 
P-labeled phosphorylase was also used as a sub-
strate instead of MLC.
 
Other Procedures
 
Immunoblotting was performed as described previously (Totsukawa et al.,
1999). Immunoreactive bands were detected with peroxidase-conjugated
secondary antibody using a chemiluminescence method (NEN). SDS-
PAGE was performed as described by Blatter et al. (Blatter et al., 1972)
using 12.5% polyacrylamide gel and the Laemmli buffer system (Laem-
mli, 1970). Protein concentrations were determined by the method of
Bradford (Bradford, 1976) using BSA as standard.
 
Results
 
Induction of Stress Fibers and Focal Adhesions by 
Inhibition of Myosin Phosphatase
 
To generate an antibody that is able to inhibit myosin
phosphatase, we chose the NH
 
2
 
-terminal region (1–296) of
chick MBS as an antigen. This region is critical for the
functions of MBS because it is responsible for the binding
to both the catalytic subunit of PP1c
 
d
 
 and the substrate,
myosin (Hirano et al., 1997). As Fig. 1 a shows, the anti-
body (termed M130Ab) specifically reacts with MBS from
a variety of nonmuscle cells including REF2A cells (lane
1), 3T3 cells (lane 2) and NRK cells (lane 3). Fig. 1 b shows
the effect of M130Ab on myosin phosphatase activity us-
ing phosphorylated MLC as a substrate. The antibody, at a
concentration of 1.7 
 
m
 
M, is able to inhibit myosin phos-
phatase activity to less than 34% of that in the absence of
the antibody. When phosphorylated phosphorylase is used
as a substrate, the antibody does not show any inhibition
(data not shown).
We microinjected the antibody into serum-starved 3T3
cells to see whether the inhibition of myosin phosphatase
results in increased MLC phosphorylation and whether an
elevation of MLC phosphorylation (if any) induces the as-
sembly of stress fibers and focal adhesions without serum
stimulation. As a control, preimmune antibody was in-
jected. As Fig. 2 shows, phalloidin staining reveals that
cells microinjected with M130Ab form parallel or stellar
stress fibers (Fig. 2, a–d) while the control injection with
Figure 1. M130Ab inhibits myosin phosphatase activity in vitro.
(a) Specificity of M130Ab. Immunoblot showing that M130Ab
raised against the NH2-terminal region (1–296) of chick MBS
specifically recognizes 130-kD MBS in a variety of nonmuscle
cells. Total cell lysates were separated by SDS-PAGE followed
by immunoblotting using M130Ab. Lane 1, REF 2A cells; lane 2,
Balb/c 3T3 cells; lane 3, NRK cells. (b) Inhibition of myosin phos-
phatase activity by M130Ab. Myosin phosphatase was first incu-
bated with M130Ab, then myosin phosphatase activity was deter-
mined using 32P-labeled MLC as a substrate. The values shown
are means 6 SEM from three independent experiments.
Figure 2. Microinjection of M130Ab induces stress fiber forma-
tion and increases MLC phosphorylation in serum-starved 3T3
cells. M130Ab (5 mg/ml) was microinjected into serum-starved
3T3 cells. FITC-dextran was coinjected to identify injected cells
(b, d, and f). 2 h after injection, cells were fixed and stained with
rhodamine-phalloidin (a–d), or anti–S19-phosphorylated MLC
antibody (e and f). Asterisks indicated uninjected cells. Bars,
10 mm. 
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preimmune antibody has no effect (data not shown). Con-
comitantly, MLC phosphorylation of injected cells is
found to be greatly increased (Fig. 2, e and f). A mono-
clonal antibody specific to S19-phosphorylated MLC stains
antibody-injected cells strongly while very weak staining is
seen with uninjected cells. The induction of stress fibers
and concomitant increase in MLC phosphorylation are
observed in about 80% of cells injected with the M130Ab
(
 
n
 
 5 
 
345).
Two types of stress fibers are formed by M130Ab injec-
tion. Most (75%) of stress fibers are parallel (Fig. 2, c and
d), while the rest exhibit stellar stress fibers radiating from
several foci (Fig. 2, a and b). When the concentration of
M130Ab is doubled, more cells show stellar stress fibers,
suggesting that the formation of stellar stress fibers de-
pends on the extent of inhibition of myosin phosphatase.
About 20–50% of MLC is phosphorylated in nonmuscle
cells under normal conditions (Yamakita et al., 1994;
Kolega and Kumar, 1999). These cells have well devel-
oped stress fibers, indicating that partial MLC phosphory-
lation is sufficient for the formation of stress fibers. It is
possible that the higher concentrations of M130Ab cause
more complete inhibition of myosin phosphatase and thus
increase MLC phosphorylation above the levels observed
under normal conditions. This may result in the formation
of stellar stress fibers. Similar stellar stress fibers were in-
duced by overexpression of constitutively active ROCK
(Leung et al., 1996; Amano et al., 1997; Ishizaki et al.,
1997). It is likely that constitutively active ROCK would
also lead to unusually high levels of MLC phosphorylation
via extensive inhibition of myosin phosphatase.
The inhibition of myosin phosphatase by M130Ab injec-
tion also induces focal adhesion assembly (Fig. 3). About
80% of injected cells show higher staining with antibodies
Figure 3. Microinjection of
M130Ab induces focal adhe-
sion formation in serum-
starved 3T3 cells. a–f:
M130Ab was microinjected
into serum-starved 3T3 cells
as in Fig. 2. Cells were fixed
and stained with anti-vincu-
lin antibody (a and b), anti-
paxillin antibody (c and d),
or anti-FAK antibody (e and
f). FITC-dextran was coin-
jected to identify injected
cells (b, d, and f). (g–j)
M130Ab-injected cells were
double stained with rho-
damine-phalloidin (h, red)
and anti-vinculin antibody (i,
green). Injected cells were
detected by anti-rabbit IgG
secondary antibody (g). A
merged image of rhodamine-
phalloidin staining (red) and
vinculin localization (green)
is shown in j. Asterisks indi-
cated uninjected cells. Bars,
10  mm. 
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against components of focal adhesions including vinculin
(Fig. 3, a and b;
 
 n 
 
5 
 
190), paxillin (Fig. 3, c and d;
 
 n 
 
5 
 
114)
and FAK (Fig. 3, e and f;
 
 n 
 
5 
 
132). Double staining with
rhodamine-conjugated phalloidin (Fig. 3 h) and the anti-
vinculin antibody (Fig. 3 i) reveals that vinculin staining is
concentrated at the ends of or along stress fibers, indicat-
ing that focal adhesions are indeed formed (Fig. 3 j). These
observations indicate that the inhibition of myosin phos-
phatase increases MLC phosphorylation, and suggest that
the increase is sufficient to induce both stress fibers and
focal adhesions. They also indicate that the heterotrimeric
myosin phosphatase is a major phosphatase controlling
MLC phosphorylation in 3T3 cells.
 
Inhibition of the Formation of Stress Fibers and Focal 
Adhesions by Constitutive Activation of
Myosin Phosphatase
 
A constitutively active mutant of MBS would be a useful
tool to examine whether the inhibition of MLC phosphor-
ylation blocks the RhoA-mediated induction of stress fi-
bers and focal adhesions. We speculated that the NH
 
2
 
 ter-
minus of MBS spanning residues 1–296 (MBS
 
296
 
) would
behave as a constitutively active mutant for the following
reasons. First, MBS
 
296
 
 when combined with PP1c
 
d
 
 has in-
creased myosin phosphatase activity compared with PP1c
 
d
 
alone (Hirano et al., 1997). This reflects the binding of
MBS
 
296
 
 to both myosin and PP1c
 
d
 
. Second, MBS
 
296
 
 may
be able to associate with PP1c
 
d
 
 because cells have a large
pool of PP1c
 
d
 
 (Fernandez et al., 1992; Andreassen et al.,
1998). Third and most importantly, MBS
 
296
 
 does not con-
tain the inhibitory phosphorylation sites. While myosin
phosphatase activity is inhibited by phosphorylation of
MBS, the inhibitory phosphorylation sites so far reported
are located towards the COOH terminus of MBS. For ex-
ample, Rho-kinase phosphorylates Thr 697 and Ser 854
(Kawano et al., 1999) and recently phosphorylation at Thr
697 has been shown to be responsible for the inhibition of
myosin phosphatase (Feng et al., 1999a). Thus MBS
 
296
 
would not be phosphorylated following microinjection
into cells and would not be subjected to regulation by
ROCK.
We microinjected MBS
 
296
 
 into serum-starved 3T3 cells
and then stimulated with serum to observe the effects on
the assembly of stress fibers and focal adhesions. As Fig. 4
shows, MBS
 
296
 
 microinjection blocks serum-induced stress
Figure 4. MBS296 inhibits
MLC phosphorylation, stress
fiber assembly, and focal ad-
hesion formation of serum-
stimulated 3T3 cells. MBS296
(1 mg/ml) was microinjected
into serum-starved 3T3 cells
30 min before serum stimula-
tion. Because subconfluent
serum-starved cells were dif-
ficult to examine for focal ad-
hesion assembly due to their
overlaps, individually sepa-
rated cells were prepared by
replating as described in Ma-
terials and Methods. Cells
were stimulated with serum
for 10 min, then fixed and
stained with rhodamine-
phalloidin (a and b), anti–
S19-phophorylated MLC
antibody (c and d), or anti–
vinculin antibody (e and f).
Note that stress fibers of the
uninjected cell at the top of
panel a are not obvious be-
cause of out of focus. As a
control, MBS278–415 was mi-
croinjected into serum-
starved 3T3 cells, and cells
were stimulated with serum
in the same way. The injec-
tion of MBS278–415 showed no
effect when examined by
rhodamine-phalloidin stain-
ing (g and h) or by anti–S19-
phophorylated MLC anti-
body (i and j). It is noticed
that MBS296-injected cells show prominent vesicles distributed circumferentially around the cells. The identity of these vesicles is cur-
rently unknown. Injected cells were detected by coinjection of FITC-dextran (b, d, f, h, and j). Asterisks indicate uninjected cells. Bars,
10 mm. 
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fiber formation though a network of microfilaments is
formed (Fig. 4, a and b;
 
 n 
 
5 
 
195). Concomitantly, MLC
phosphorylation stays very low in injected cells (Fig. 4, c
and d;
 
 n 
 
5 
 
187) while noninjected cells show greatly in-
creased MLC phosphorylation upon serum stimulation
(indicated by asterisks). Focal adhesion assembly is also
blocked (Fig. 4, e and f;
 
 n 
 
5 
 
131). As a control, we injected
the central region of MBS, residues 278–415, and found no
effect on stress fiber formation (Fig. 4, g and h;
 
 n 
 
5 
 
89) or
MLC phosphorylation (Fig. 4, i and j;
 
 n 
 
5 
 
84). These ob-
servations, together with the results of the M130Ab injec-
tion, indicate that MLC phosphorylation is both necessary
and sufficient for the induction of stress fibers and focal
adhesions. The formation of the network of microfila-
ments in the MBS
 
296
 
-injected cells (arrowhead in Fig. 4 a)
indicates that serum-induced actin polymerization is not
blocked by MBS
 
296
 
. This observation is consistent with
the report by Watanabe et al. (1999) demonstrating that
 
mDia
 
, another RhoA effector, is responsible for the
RhoA-induced actin polymerization.
 
Distinct Roles of ROCK (Rho-Kinase) and MLCK in 
Spatial Regulation of MLC Phosphorylation
 
The increase of MLC phosphorylation by inhibition of my-
osin phosphatase (Fig. 2, e and f) indicates the presence of
active MLC kinase(s) in serum-starved cells. MLCK and
ROCK are possible candidates. To determine which ki-
nase(s) is involved, serum-starved 3T3 cells were treated,
before M130Ab injection, with kinase inhibitors, Y-27632
or ML-9, to inhibit ROCK (Uehata et al., 1997) or MLCK
(Saitoh et al., 1987), respectively. As Fig. 5 shows, these in-
hibitors produce distinctive effects on the microfilament
organization in M130Ab-injected cells. The ROCK inhibi-
tor, Y-27632, blocks the formation of stress fibers in the
center of injected cells (Fig. 5, a and b;
 
 n 
 
5 
 
178). Interest-
ingly, however, thick cortical actin bundles are induced
along the cell periphery of M130Ab-injected cells (Fig. 5
a). These fibers are stained with the monoclonal antibody
against S19-phosphorylated MLC (Fig. 5, c and d;
 
 n 
 
5
 
139), and contain focal adhesions as revealed by vinculin
staining (Fig. 5, e and f;
 
 n 
 
5 
 
107). These observations sug-
gest that ROCK is responsible for MLC phosphorylation
in the center of cells but not at the cell periphery. Phos-
phorylation by ROCK of other of its substrates (including
moesin, adducin, and intermediate filament proteins) is
not required for focal adhesion assembly.
The MLCK inhibitor, ML-9, on the other hand, does not
inhibit the formation of M130Ab-induced stress fibers
(Fig. 5, g and h;
 
 n 
 
5 
 
121). The stress fibers are again stained
strongly with the monoclonal antibody against S19-phos-
phorylated MLC (data not shown). These results suggest
that MLCK is not a major kinase responsible for stress fi-
ber assembly in the center of 3T3 cells. MLCK, however,
seems to be involved in the phosphorylation and assembly
of peripheral microfilament bundles. When the two inhibi-
tors are added simultaneously, the peripheral microfila-
ment bundles that are formed in the presence of Y-27632
alone are not induced (Fig. 5, i and j;
 
 n 
 
5 
 
141).
Similar spatially differentiated regulation by these two
kinases is also observed with 3T3 cells growing in the
presence of serum. Exponentially growing cells were first
treated with either Y-27632 or ML-9, and then M130Ab
was injected. As reported previously (Uehata et al., 1997),
the treatment with Y-27632 disassembles stress fibers (Fig.
5 k, see uninjected cells indicated by asterisks). Inhibition
of myosin phosphatase by microinjection of M130Ab in-
duces the formation of similar peripheral microfilament
bundles, but no stress fibers are found in the center (Fig. 5,
k and l;
 
 n 
 
5 
 
150). Unlike Y-27632, treatment with ML-9
does not markedly affect the assembly of stress fibers of
3T3 cells growing in the presence of serum (Fig. 5 m, see
uninjected cells indicated by asterisks). Microinjection of
M130Ab, however, frequently produces stellar stress fi-
bers in the center of cells and injected cells seem to be con-
tracted (Fig. 5, m and n;
 
 n 
 
5 
 
175). This is probably due to
an increased inhibition of myosin phosphatase (by M130Ab)
in addition to the inhibition induced by ROCK in the pres-
ence of serum.
If MLCK is responsible for the formation of peripheral
microfilament bundles, MLCK should be localized in such
bundles. Serum-starved 3T3 cells were again treated with
Y-27632 and injected with the M130Ab to induce periph-
eral microfilament bundles. To examine the localization of
MLCK in 3T3 cells injected with the M130Ab (rabbit anti-
body), the goat anti-MLCK antibody (de Lanerolle et al.,
1987) was used. As Fig. 6, a–c, shows, the peripheral mi-
crofilament bundles (arrowheads in b, rhodamine-phalloi-
din) were stained with the anti-MLCK antibody (arrow-
heads in c; 
 
n
 
 5 
 
123). Similar localization of MLCK was
found in 3T3 cells grown in the presence of serum (Fig 6,
d–f,
 
 n 
 
5 
 
95). The anti-MLCK antibody stained peripheral
microfilament bundles (e, rhodamine-phalloidin; f, MLCK)
though the background of MLCK staining was higher than
that seen in the absence of serum. These results support
that MLCK is responsible for the phosphorylation of MLC
at the cell periphery.
 
Discussion
 
Using the two newly developed reagents with the oppos-
ing effects on myosin phosphatase, we have demonstrated
that MLC phosphorylation is not only necessary but also
sufficient to induce the assembly of stress fibers and focal
adhesions. This result strongly supports the model for the
assembly of stress fibers and focal adhesions proposed ear-
lier by Burridge and coworkers (Chrzanowska-Wodnicka
and Burridge, 1996) that myosin II–based contractility is
the force that drives the assembly of stress fibers and focal
adhesions. The contractility is essential because simple
actin bundling by an actin bundling protein such as fascin
failed to produce stress fibers when injected into serum-
starved 3T3 cells (data not shown).
It is worthy of note that focal adhesion assembly can be
induced by MLC phosphorylation alone even when the
RhoA/ROCK (Rho-kinase) activity is blocked. Focal ad-
hesions are formed along the peripheral microfilament
bundles that are induced by M130Ab injection in the pres-
ence of Y-27632 (Fig. 5, a–f). Similar peripheral bundles
and focal adhesions are formed in the presence of Toxin B,
a bacterial toxin that blocks Rho activity (Just et al., 1994).
These results suggest that other RhoA/ROCK-mediated
factors (such as phosphorylation of other substrates by
ROCK or an elevation of PIP2 levels) may not be essential 
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for focal adhesion assembly. Perhaps, vinculin in serum-
starved cells is in a PIP2-bound state. Microfilaments in se-
rum-starved cells are thus likely to stay associated with
vinculin and other focal adhesion components but be dis-
persed due to the lack of active myosin. Activation of my-
osin would simply bring such microfilaments together to
form focal adhesions.
Our results suggest that ROCK’s ability to directly phos-
phorylate MLC is significant in 3T3 cells. This is based on
the observation that, when ROCK is blocked by Y-27632,
inhibition of myosin phosphatase via microinjection of
M130Ab did not form stress fibers in the center of cells
(though peripheral microfilament bundles were formed,
see Fig. 5). The simplest interpretation of this observation
is that the MLC kinase activity of ROCK and its known
function of inhibiting myosin phosphatase by phosphory-
lating MBS are both essential for stress fiber assembly in
the center of cells. We can not exclude the possibility,
however, that, under different conditions or in other types
of cells, MLCK can play a more significant role in MLC
Figure 5. Effects of ROCK or MLCK inhibitors on M130Ab-induced stress fiber and focal adhesion assembly. Serum-starved 3T3 cells
were first treated for 30 min with 10 mM Y-27632 alone (a–f), 10 mM ML-9 alone (g and h) or both 10 mM Y-27632 and 10 mM ML-9 (i
and j). M130Ab (5 mg/ml) was then microinjected together with FITC-dextran. 2 h after injection, cells were fixed and stained with
rhodamine-phalloidin (a, b, and g–j), anti S19-phosphorylated MLC antibody (c and d), or anti-vinculin antibody (e and f). In k–n, 3T3
cells grown with 10% serum were pretreated with 10 mM Y-27632 (k and l) or 10 mM ML-9 (m and n) for 30 min, and microinjected with
M130Ab. 2 h after injection, cells were fixed and stained with rhodamine-phalloidin. Injected cells were detected by coinjected FITC-
dextran (b, d, f, h, j, l and n). Uninjected cells are indicated by asterisks. Bars, 10 mm. 
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phosphorylation than ROCK. This appears to be the case
in smooth muscle cells: ROCK functions mainly as an in-
hibitor of myosin phosphatase under physiological condi-
tions (Iizuka et al., 1999).
Interestingly, we have found that the two different MLC
kinases of ROCK and MLCK function at different cellular
locations to induce assembly of distinct sets of microfila-
ment bundles in 3T3 cells. As illustrated in Fig. 7, ROCK
is involved in the formation of stress fibers in the center of
cells, while MLCK functions at the periphery. In the cen-
ter of cells (a), ROCK controls not only MLC phosphory-
lation (by direct phosphorylation) but also MLC dephos-
phorylation (by inhibiting myosin phosphatase). MLCK
appears not to be involved in the MLC phosphorylation.
At the cell periphery (b), on the other hand, the major role
of ROCK is to control MLC dephosphorylation through
inhibiting myosin phosphatase. MLCK is likely to be the
kinase responsible for MLC phosphorylation. Because the
ROCK inhibitor does not affect the assembly of periph-
eral microfilament bundles, the Rho/ROCK pathway does
not appear to regulate MLCK. It should be noted, how-
ever, that the spatially differentiated regulation of MLC
phosphorylation by these two kinases may vary depending
on cell types and contractile activities.
What mechanism could make the two MLC kinases
function at different cellular locations? One possibility is
Figure 6. Localization of MLCK in
cortical actin bundles induced by
M130Ab injection in the presence of
Y-27632. Serum-starved 3T3 cells (a–c)
or 3T3 cells grown with 10% serum
(d–f) were first treated for 30 min with
10 mM Y-27632, and M130Ab (5 mg/
ml) was then microinjected. 2 h after
injection, cells were fixed and double
stained with rhodamine-phalloidin (b
and e) or anti-MLCK antibody (c and
f). Injected cells were detected by anti-
rabbit IgG secondary antibody (a and
d). Arrowheads indicate cortical actin
bundles. Asterisks indicate uninjected
cells. Bars, 10 mm.
 
that the upstream signals to activate each kinase may work
at different locations. For example, if calcium concentra-
tion is high at the cell periphery, then MLCK would be-
come preferentially active in such a location. In addition,
the difference in their intracellular localizations partly ex-
plains the spatially differentiated regulation. ROCK is dif-
fusely localized in the center (or perinuclear) region of
cells. While MLCK was reported to be localized on stress
fibers (de Lanerolle et al., 1981; Guerriero et al., 1981), a
close examination of the work by Guerriero et al. (1981)
has revealed that MLCK is localized more prominently on
cortical microfilament bundles at the cell periphery of 3T3
cells.
The spatially differentiated regulation by the two MLC
kinases is likely to provide a mechanism to regulate MLC
phosphorylation in localized regions of the cell and by the
different upstream stimuli. In addition, this system would
be able to confer very different contractile activities on ac-
tomyosin depending on which kinase is responsible. Ac-
cording to the kinetic data (Amano et al., 1996; Feng et
al., 1999b), MLCK phosphorylates the substrate 2–7
times more rapidly than does ROCK while the Km of
ROCK appears to be 15–20 times lower than that of
MLCK. This suggests that MLCK would cause rapid con-
traction though the higher Km value may require close
contact between MLCK and myosin. ROCK, on the other 
Totsukawa et al. 
 
Spatial Regulation of MLC Phosphorylation
 
805
 
hand, would be able to induce contraction (though more
slowly) even if the concentrations of ROCK and myosin
are low. Indeed, ROCK is diffusely present throughout
the cell. The contractility of peripheral microfilament bun-
dles is thus predicted to be more responsive to the up-
stream stimuli than that of stress fibers. Future studies
should be directed toward elucidating how the two kinases
regulate, both in space and time, complex contractile pro-
cesses such as cell division, neurite retraction and cell mi-
gration.
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